Updated COVID-19 vaccines are being rolled out in the U.S., aimed at targeting the latest, prevalent variants of the disease. Here we answer common questions about the latest vaccines.
Background Science
Q&A on Mpox
What VAERS Can and Can’t Do, and How Anti-Vaccination Groups Habitually Misuse Its Data
Q&A on RSV Maternal Vaccine and Antibody Candidates to Protect Infants
Nearly all children get sick from respiratory syncytial virus, or RSV, by the age of 2, and last year, there was a notable surge in RSV-associated hospitalizations. But the Food and Drug Administration is now considering approval of a vaccine and a monoclonal antibody aimed at protecting infants from this common virus.